F-Star Therapeutics Inc (FSTX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

35 PARKWOOD DRIVE CAMBRIDGE, UNITED KINGDOM CB22 3AT

F-star is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. By developing medicines that seek to block tumor immune evasion, the Company's goal is to offer patients greater and more durable benefits than current immuno-oncology treatments. Through its proprietary tetravalent, bispecific natural antibody (mAb²™) format, F-star's mission is to generate highly differentiated best-in-class drug candidates with monoclonal antibody-like manufacturability.

Data as of 2021-09-19 13:02:16 -0400
Market Cap156.506 Million Shares Outstanding20.62 Million Avg 30-day Volume93.556 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE7.07 Enterprise Value
Total Cash Current Debt Gross Profit
BETA2.40822 52-week High/Low15.5 / 1.15 Next Earnings Date2021-11-03 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from FSTX instead.

View recent insider trading info

Funds Holding FSTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding FSTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KAYITALIRE LOUIS CHIEF MEDICAL OFFICER

  • Officer
54,383 2021-07-02 6

ARKOWITZ DAVID

  • Director
20,000 2021-06-04 2

BERMINGHAM NESSAN

  • Director
20,000 2021-06-04 5

BRADY TODD C

  • Director
20,000 2021-06-04 3

KLEIN PAMELA M.

  • Director
20,000 2021-06-04 1

KROL PATRICK JOHAN HENDRIK

  • Director
20,000 2021-06-04 2

BENZ EDWARD JR

  • Director
20,000 2021-06-04 4

RACE GEOFFREY

  • Director
20,000 2021-06-04 3

DEPTULA-HICKS DARLENE M TREASURER AND CFO

  • Officer
54,320 2021-03-09 5

BREWIS NEIL CHIEF SCIENTIFIC OFFICER

  • Officer
99,180 2021-03-09 4

FORSTER ELIOT PRESIDENT AND CEO

  • Officer
  • Director
388,901 2021-03-09 4

DRISCOLL MARTIN J PRESIDENT AND CEO

  • Officer
  • Director
No longer subject to file 2020-11-19 1

EICHLER KURT M

  • Director
No longer subject to file 2020-11-19 1

IYER RADHAKRISHNAN P. CHIEF SCIENTIFIC OFFICER

  • Officer
No longer subject to file 2020-11-19 1

WINSLOW GARRETT GENERAL COUNSEL AND SECRETARY

  • Officer
No longer subject to file 2020-11-19 1

FIRMANI LORI VP OF FINANCE AND TREASURER

  • Officer
No longer subject to file 2020-11-19 1

CLACKSON TIMOTHY P

  • Director
50,486 2020-09-30 1

SMITH SCOTT ANDREW

  • Director
0 2020-06-24 0

FREVE JONATHAN CFO & TREASURER

  • Officer
0 2020-03-05 0

AFDHAL NEZAM H. CHIEF MEDICAL OFFICER

  • Officer
0 2019-01-24 0

BARDON CHRISTIANA

  • Director
  • 10% Owner
890,959 2018-10-01 0

BATES JONATHAN

  • Director
0 2018-06-18 0

MPM ONCOLOGY IMPACT MANAGEMENT GP LLC

MPM ONCOLOGY IMPACT MANAGEMENT LP

ONCOLOGY IMPACT FUND (CAYMAN) MANAGEMENT L.P.

UBS ONCOLOGY IMPACT FUND L.P.

  • 10% Owner
833,839 2017-03-25 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
F-STAR THERAPEUTICS INC FSTX 2021-09-24 22:15:03 UTC -0.2833 0.3533 30000
F-STAR THERAPEUTICS INC FSTX 2021-09-24 21:45:03 UTC -0.2792 0.3492 30000
F-STAR THERAPEUTICS INC FSTX 2021-09-24 21:15:03 UTC -0.2792 0.3492 30000
F-STAR THERAPEUTICS INC FSTX 2021-09-24 20:45:03 UTC -0.2836 0.3536 30000
F-STAR THERAPEUTICS INC FSTX 2021-09-24 20:15:03 UTC -0.2836 0.3536 30000
F-STAR THERAPEUTICS INC FSTX 2021-09-24 19:45:03 UTC -0.2836 0.3536 30000
F-STAR THERAPEUTICS INC FSTX 2021-09-24 19:15:03 UTC -0.2836 0.3536 30000
F-STAR THERAPEUTICS INC FSTX 2021-09-24 18:45:03 UTC -0.2836 0.3536 30000
F-STAR THERAPEUTICS INC FSTX 2021-09-24 18:15:03 UTC -0.2836 0.3536 30000
F-STAR THERAPEUTICS INC FSTX 2021-09-24 17:45:03 UTC -0.2836 0.3536 30000
F-STAR THERAPEUTICS INC FSTX 2021-09-24 17:15:03 UTC -0.2836 0.3536 30000
F-STAR THERAPEUTICS INC FSTX 2021-09-24 16:45:03 UTC -0.3132 0.3832 30000
F-STAR THERAPEUTICS INC FSTX 2021-09-24 16:15:03 UTC -0.3132 0.3832 30000
F-STAR THERAPEUTICS INC FSTX 2021-09-24 15:45:03 UTC -0.3132 0.3832 30000
F-STAR THERAPEUTICS INC FSTX 2021-09-24 15:15:04 UTC -0.3132 0.3832 30000
F-STAR THERAPEUTICS INC FSTX 2021-09-24 14:45:02 UTC -0.315 0.385 30000
F-STAR THERAPEUTICS INC FSTX 2021-09-24 14:15:02 UTC -0.315 0.385 30000
F-STAR THERAPEUTICS INC FSTX 2021-09-24 13:45:02 UTC -0.315 0.385 45000
F-STAR THERAPEUTICS INC FSTX 2021-09-24 13:15:03 UTC -0.315 0.385 45000
F-STAR THERAPEUTICS INC FSTX 2021-09-24 12:45:03 UTC -0.315 0.385 45000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments